Search for: "Bond v. Merck "
Results 1 - 19
of 19
Sorted by Relevance
|
Sort by Date
25 Apr 2018, 12:08 pm
V. [read post]
16 Mar 2011, 5:34 am
§ 240.10b-5.In doing so, the Second Circuit addressed the gap left by the United States Supreme Court in Merck & Co. v. [read post]
28 Feb 2011, 12:30 pm
As we predicted, see Merck Lawyer Takes Nicks on Question of Timely Securities Complaint in Supreme Court, the Supreme Court in 2010 agreed with us in Merck & Co. v. [read post]
16 Oct 2010, 10:20 pm
Merck & Co. [read post]
13 Sep 2012, 4:26 pm
On its own motion, the Court stayed further briefing in this matter pending action by the United States Supreme Court in Merck & Co. v. [read post]
5 May 2010, 6:59 am
In securities fraud cases, held the Court, facts showing scienter are among those that constitute the violation (Merck & Co., Inc. v. [read post]
10 Aug 2008, 12:46 am
" One recalls that the recent Supreme court case involving Merck and Integra (drug companies) could just as well have been captioned Scripps v. [read post]
25 Jan 2007, 5:28 pm
Evidently, Maclachlan hasn't heard about 35 USC 271(e)(1) or Merck v. [read post]
29 Jul 2011, 9:13 am
” Merck & Co. v. [read post]
17 Sep 2007, 2:00 pm
., v. [read post]
22 Jan 2007, 6:22 pm
Companies will still need a license when they want to bring the research into their company laboratories or when they want to develop a product for the market.Given that stem cell research is within the area covered by the exemption of 35 USC 271(e)(1) as interpreted by Merck v. [read post]
7 Dec 2009, 3:00 am
Bombardier Rec (PATracer) Magotteaux - ITC issues an opinion on remedy, the public interest, and bonding in certain composite wear components (337-TA-644) (ITC Law Blog) Minemyer - N D Illinois delays trial for one year to allow incarcerated plaintiff to attend: Minemyer v. [read post]
17 Jul 2008, 6:49 pm
They did it in Riegel v. [read post]
24 May 2007, 10:40 am
Parke-Davis, 733 P.2d 507, 515-16 (Wash. 1987); Bond v. [read post]
26 Jan 2011, 12:54 am
One notable exception is the statute of limitations, an issue where the Supreme Court provided a favorable ruling this year in Merck.* Of course, that ruling was influenced by the heightened requirements for pleading scienter in a securities fraud action that make it virtually impossible for an investor to assert a claim of fraud until there is clear evidence of fraudulent intent. [read post]
25 May 2011, 11:46 pm
The irony is that the new rigid rule, in the name of tightening, actually loosens the bonds obliging honesty. [read post]
23 May 2008, 1:03 am
- Generic manufacturers aggressively promote expensive doxofylline over price controlled equivalent theophylline: (Spicy IP), Middle East – Ranbaxy strengthens presence in Middle East region: (GenericsWeb), Scotland: Future funding of stem cell companies in Scotland dependent on EPO Enlarged Board of Appeals’ decision on stem cell patentability: (IP finance), South Africa: More on AIDS/access debate - Patrick Bond article on Thabo Mbeki’s AIDS policy: (Afro-I [read post]
18 Sep 2005, 7:10 pm
The Vioxx VerdictsThe legal community is still abuzz about the $253 million verdict against Merck & Co., Inc. [read post]
28 Mar 2022, 12:50 am
Merck is appealing to the NARB. [read post]
